| Project/Area Number |
15K15352
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Metabolomics
|
|---|
| Research Institution | National Institute for Physiological Sciences |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
OKAMOTO Shiki 琉球大学, 医学研究科, 特命講師 (40342919)
YOKOTA Shigefumi 生理学研究所, 生体機能調節研究領域, NIPSリサーチフェロー (50725281)
|
|---|
| Research Collaborator |
SAITO Kumiko 生理学研究所, 技術課, 係長
|
|---|
| Project Period (FY) |
2015-04-01 – 2017-03-31
|
| Project Status |
Completed (Fiscal Year 2016)
|
| Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2015: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Keywords | AMPK / streptozotocin / myokine / leptin / ストレプトゾトシン / 1型糖尿病 / Myokine |
|---|
| Outline of Final Research Achievements |
AMP kinase (AMPK) is a metabolic sensor that plays an important role in obesity and diabetes. I found that muscle-specific dominant negative AMPK-epxressing transgenic mice (DN-AMPK Tg mice) suppress metabolic abnormalities in streptozotocin-inducd type 1 diabetes. The study revealed that IL-6, irisin, and leptin are involved in the effects of muscle DN-AMPK on streptozotocin-inducd diabetes.
|
